2 patents currently held
23 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2028. from the record
Of the 23 now held by other companies, 16 name Epc Nextaste Pte Ltd. as their current owner, and 7 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Jun 2028
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Jun 2028 · High confidence
Also notable
Ends Nov 2044 · High confidence
Process for the Preparation of Xanthophyll Crystals
US 8,034,983
Renewed at every maintenance window since the 2011 grant; no more fees are due before its term ends in 2028.
Sweetener and Flavor Composition Comprising Glycosylated High Purity Steviol Glycosides
US 12,708,128
A family of 27 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2044.
Formerly held, still cited
Notable
Ends Aug 2030 · High confidence
The most cited patent in this portfolio, cited by 117 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2030.
now held by Tate & Lyle Technology Limited
Also notable
Ends Feb 2036 · High confidence
Cited by 18 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2036.
now held by Tate & Lyle Technology Limited
Also notable
Ends Jun 2030 · High confidence
Cited by 23 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2030. A terminal disclaimer caps this term to an earlier patent's.
now held by Tate & Lyle Technology Limited
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Sweetener and Flavor Composition Comprising Glycosylated High Purity Steviol Glycosides | 1 in force | to Nov 2044 |
| Process for the Preparation of Xanthophyll Crystals | 1 in force | to Jun 2028 |
Patents held now
Soonest term end first.
Showing 1 to 2 of 2
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,034,983 | Process for the Preparation of Xanthophyll Crystals In force · High confidence | In force | High confidence | |
| US 12,708,128 | Sweetener and Flavor Composition Comprising Glycosylated High Purity Steviol Glycosides In force · High confidence | In force | High confidence |
Also on record, not counted in the 2: 23 patents in force now held by others · 3 patents ended · 4 applications pending · 21 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed